IMUX earnings date and last-quarter result: next report 2026-08-06, last quarter miss, P/E -2.53. Updated 2026-07-23.
Immunic (IMUX) Research Hub
Immunic (IMUX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 7.28 USD (-1.75%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.53, market cap 0.15B. This hub links to the full technical, earnings and options research available for IMUX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 7.28 USD (-1.75%) |
| 52-week range | 6.35 USD – 17.43 USD |
| Trend regime | Range |
| 14-day RSI | 43.4 (Bearish) |
| Trailing P/E | -2.53 |
| Market cap | 0.15B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for IMUX
Covered Call on IMUX: how it works, illustrative setup around the real 7.28 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IMUX: how it works, illustrative setup around the real 7.28 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IMUX: how it works, illustrative setup around the real 7.28 USD price, max profit/loss, breakeven and when to use it. Educational.
IMUX technical analysis: range, last 7.28 USD, RSI 43.4, 52w range 6.35 USD–17.43 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is IMUX in?
Immunic (IMUX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is IMUX in an uptrend or downtrend?
As of 2026-10-26, IMUX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IMUX's trailing P/E ratio?
IMUX's trailing P/E is -2.53, with a market cap of 0.15B. See the earnings research page for full valuation detail.
When does IMUX next report earnings?
IMUX is next scheduled to report earnings on 2026-08-06.